Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-27

Clinical Trial Update: A Study of Doxycycline to Treat Chlamydial Infection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating doxycycline for the treatment of Chlamydia trachomatis infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chlamydial Infection | Phase 4 | Status: COMPLETED